<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00204425</url>
  </required_header>
  <id_info>
    <org_study_id>Bio 03-1077</org_study_id>
    <secondary_id>124322 FRN68095</secondary_id>
    <nct_id>NCT00204425</nct_id>
  </id_info>
  <brief_title>Effect of Exercise Training and Soy-based Nutritional Supplementation on Prevention of Osteoporosis</brief_title>
  <official_title>Effect of Combined Exercise Therapy and Isoflavone Supplementation on Prevention of Osteoporosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Saskatchewan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Saskatchewan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the effectiveness of combining exercise training
      (i.e. weight lifting and walking) and dietary supplementation with a soy-based nutritional
      supplement for increasing bone mineral density. We hypothesize that the exercise training and
      soy-based supplement will be additive for increasing bone mineral density.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Exercise training is effective for increasing bone mineral density and preventing
      osteoporosis, but the effects are small. When estrogen replacement is given to
      post-menopausal women the effectiveness of exercise training for improving bone mineral
      density is increased. Currently many women are concerned about the risks of taking
      hormone-replacement therapy and are seeking alternative therapies. The purpose of our study
      therefore is to use an estrogen-like dietary supplement derived from soy called a
      phytoestrogen (soy isoflavone) combined with exercise training for improving bone mineral
      density.

      Comparisons: Four groups are being compared: 1) Exercise training (i.e. weight lifting 2
      times per week and walking 4 times per week) plus soy isoflavone (90 mg aglycone equivalents
      per day); 2) Exercise training plus placebo; 3) Exercise placebo (flexibility exercises four
      times per week) plus soy isoflavone; 4) Exercise placebo plus placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lumbar spine bone mineral density at 12 and 24 months</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density of the proximal femur at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density of the whole body at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone quality of the radius and tibia (ultrasound) at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometry of the proximal femur at at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lean tissue mass at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist girth at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular strength at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-paced walking ability at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Balance at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flexibility at 12 and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast density at 24 months</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endometrial thickness at 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Menopausal symptoms at 3, 6, 9, 12, 15, 18, 21, and 24 months.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">351</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Osteopenia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercise/soy isoflavone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercise/isoflavone placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>exercise placebo/soy isoflavone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>exercise placebo/isoflavone placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>exercise/soy isoflavone</intervention_name>
    <description>Exercise 6 days per week, 90 mg/day aglycone isoflavone Exercise placebo (stretching), isoflavone placebo</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <other_name>Archer Daniels Midland</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post-menopausal women

        Exclusion Criteria:

          -  Diagnosed osteoporotic

          -  Previous fragility fractures

          -  Previous breast cancer

          -  Previous endometrial cancer

          -  Taken bisphosphonates in past 12 months

          -  Taken hormone replacement therapy in past 12 months

          -  Taken selective estrogen receptor modulators in past 12 months

          -  Taken parathyroid hormone in past 12 months

          -  Taken calcitonin in past 12 months

          -  Currently taking corticosteroids

          -  Currently taking a thiazide diuretic

          -  Crohn's Disease

          -  Cushing Disease

          -  Allergy to soy

          -  Severe osteoarthritis

          -  Currently participating in vigorous exercise
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip D Chilibeck, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H J Biem, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Allison Case, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olufemi Olantunbosun, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Pierson, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan Whiting, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Punam Pahwa, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Saskatchewan</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 5B2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Chilibeck PD. Exercise and estrogen or estrogen alternatives (phytoestrogens, bisphosphonates)for preservation of bone mineral in postmenopausal women. Can J Appl Physiol. 2004 Feb;29(1):59-75. Review.</citation>
    <PMID>15001805</PMID>
  </reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>September 9, 2011</last_update_submitted>
  <last_update_submitted_qc>September 9, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Saskatchewan</investigator_affiliation>
    <investigator_full_name>Phil Chilibeck</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Osteoporosis</keyword>
  <keyword>Bone</keyword>
  <keyword>Exercise</keyword>
  <keyword>Soy</keyword>
  <keyword>Isoflavone</keyword>
  <keyword>Phytoestrogen</keyword>
  <keyword>Menopause</keyword>
  <keyword>Lipids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

